The creation of a ‘burden to dope’ provides a more serious
challenge to the availability of nootropic drugs,
whether it be directly from another agent (such as an employer)
or a more implicit burden to ‘keep up’ with other
agents who are using cognitive enhancing drugs. However,
to suggest that legal banning such substances would remove
such a burden ignores the fact that this burden
already exists within certain populations; in an environment
of unregulated supply and lack of medical monitoring.